Pacific biosciences of california stock.

And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics 11/20/23-9:07AM EST Seeking Alpha Pacific Biosciences of California rises after UBS upgrades on strong ...MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.

Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...

24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq News. PacBio Announces …Common Stock, par value $0.001 per share. PACB. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, …Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC .In other news, insider Susan G. Kim sold 19,257 shares of Pacific Biosciences of California stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $8.44 ...Pacific Biosciences of California Stock Forecast and Price Target. Year-long price target forecasts from four prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $10.50. This potential gain of 24.41 percent from the previous closing price in November, 2023 is calculated on …

Nov 13, 2023 · Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%.

The Pacific Biosciences of California stock prediction for 2025 is currently $ 21.57, assuming that Pacific Biosciences of California shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 157.52% increase in the PACB stock price.

PacBio Also Closes $300 Million PIPE Financing in Support of Transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based …Mar 3, 2023 · Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase.Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...Nov 15, 2023 · Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Nov 17, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering.Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as …

As of November 1, 2023, Canaccord Genuity analyst Kyle Mikson has reaffirmed a Buy rating on Pacific Biosciences (NASDAQ:PACB), although ... Best stocks to buy now; Categories. Crypto; Dow Jones today; Pre-IPO and startups; Tech stocks; Utility stocks; Best Stocks tools HOT. Stock News Sentiment;Dec 4, 2023 · Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session. Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ... Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Two of Cathie Wood's Ark Invest ETFs loaded up on shares of Pacific Biosciences of California (PacBio). PacBio is an innovative disruptor in the genetic sequencing market. However, the company ...And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences of California Stock Up 4.7 %. Pacific Biosciences of California stock opened at $8.88 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.43 and a ...Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 29, 2023

Transcript : Pacific Biosciences of California, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 12:55 PM Sep. 12: CI Pacific Biosciences of California Introduces Program for Customers to Lease its Sequencing Systems Sep. 12: MT

As of September 25, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.46. Pacific Biosciences of California Inc is down 5.37% from its previous closing price of $8.94. During the last market session, Pacific Biosciences of California Inc’s stock traded between $8.88 and $9.11.Dec 1, 2023 · The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks. Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, balance sheet, cash flow, and market cap for the second quarter of 2023.The firm now holds 59,626 shares of the biotechnology company’s stock, after selling 59,343 shares in the quarter. According to financial data as of the end of the reporting period, these holdings were valued at $793,000. Pacific Biosciences of California is a renowned biotechnology company that specializes in genetic sequencing …Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.Pacific Biosciences of California (NASDAQ:PACB) ... The stock is currently trading at $7.59. UBS estimates ~34% revenue growth in 2024, and a revenue CAGR of 42% in 2022-2026.Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...١٣‏/٠٩‏/٢٠٢٣ ... Pacific Biosciences of California Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ... The Relative Strength (RS) Rating for Pacific ...During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 3.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $8.48, reflecting an intraday loss of -3.53% or -$0.31. The 52-week high for the ...See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.

These 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ...Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq News. PacBio Announces …MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the …Instagram:https://instagram. insider transactions stocks1964 nickels worth moneypffa dividend historyduk stock dividend Nov 26, 2023 · Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during … how to buy airbnb stocktoptier.trader Pacific Biosciences' Q3 2023 highlighted the adoption of their Revio system, particularly among new customers. Read why PACB stock is a Buy. forex programs Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Pacific Biosciences of California has a 12-month low of $5.74 and a 12-month high of $14.55. The stock has a market capitalization of $2.26 billion, a PE ratio of -6.65 and a beta of 1.72. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Pacific Biosciences of California ( NASDAQ:PACB – …